Want to see GB:HIK full AI Analyst Report?
Hikma Pharmaceuticals (HIK) Revenue
Hikma Pharmaceuticals Revenue
Hikma Pharmaceuticals had a revenue of 1.71B in the quarter ending Jun 30, 2026, with 0.87%. This bring the company's revenue in the last twelve months to 3.41B, Increased 1.66%. In the fiscal year ending Dec 31, 2025, Hikma Pharmaceuticals had annual revenue of 3.35B with 7.10% growth.
- Revenue (ttm)
- 3.41B
- Revenue Growth
- 2.48%
- P/S Ratio
- 1.07
- Revenue/Employee
- GBP 352,526
- Employees
- 9,500
- Market Cap
- GBP 3.58B
Revenue Chart
Hikma Pharmaceuticals Revenue - Annual
Revenue History
| Fiscal End Date | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 3.35B | 222.00M | 7.10% |
| Dec 31, 2024 | 3.13B | 252.00M | 8.77% |
| Dec 31, 2023 | 2.88B | 358.00M | 14.22% |
| Dec 31, 2022 | 2.52B | -36.00M | -1.41% |
| Dec 31, 2021 | 2.55B | 212.00M | 9.06% |
| Dec 31, 2020 | 2.34B | 134.00M | 6.07% |
| Dec 31, 2019 | 2.21B | 137.00M | 6.62% |
| Dec 31, 2018 | 2.07B | 134.00M | 6.92% |
| Dec 31, 2017 | 1.94B | ― | ― |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.